BIONTECH SE (BNTX) NPV
Share news, reports & tips
16 October 2020 15:23
(Sharecast News) - Pfizer and BioNTech's Covid-19 vaccine candidate could be ready for use by the end of November, the boss of the former company, Albert Bourla, said.
7 October 2020 15:24
(Sharecast News) - Europe's main drug regulator has begun a 'rolling review' of data for BioNTech and Pfizer's BNT162b2 Covid-19 vaccine candidate.
15 September 2020 23:25
(Sharecast News) - Pfizer's phase three clinical trial for its Covid-19 vaccine candidate has encountered no safety problems even after over 12,000 volunteers had been administered a second dose.
9 September 2020 12:52
(Sharecast News) - One of the Covid-19 vaccine candidates being developed by German outfit BioNTech and Pfizer succeeded in pre-clinical challenge trials.
9 September 2020 12:23
(Sharecast News) - Pfizer and BioNTech have struck a deal to supply the European Union's members states with 200m doses of a potential Covid-19 vaccine, it was announced on Wednesday.
4 September 2020 16:22
(Sharecast News) - Moderna is slowing the enrollment of volunteers in its phase three clinical trial for its Covid-19 vaccine candidate in order to ensure that minorities, who are among the most at risk...
22 July 2020 12:21
(Sharecast News) - The US government is to spend $2bn acquiring the first 100m doses of a potential vaccine for Covid-19 currently being jointly developed by Pfizer and BioNTech.
20 July 2020 14:14
(Sharecast News) - Biontech and Pfizer shares rallied on Monday after the companies said preliminary data from their Covid-19 vaccine trial showed that it was able to stimulate antibody and T-cell responses.
20 July 2020 07:56
(Sharecast News) - Stocks have recovered from early selling following news that European Union leaders meeting in Brussels had made progress on the terms for a reconstruction fund.
17 July 2020 15:15
(Sharecast News) - A vaccine against Covid-19 could be available in the US in late 2020, Goldman Sachs said.
13 July 2020 13:15
(Sharecast News) - Stocks in Europe are bumping up against multi-month highs at the beginning of the second quarter earnings season on both sides of the Atlantic, despite some analysts' reservations,...
13 July 2020 12:35
(Sharecast News) - Research into potential Covid-19 vaccines being developed by Pfizer and BioNTech has been granted so-called Fast Track designation by the US Food and Drug Administration, sending shares in...
Company announcements Announcements
No company announcements about BIONTECH SE NPV were found.
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2020. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.